Rare cancer study seeks clues in blood and lab models

This study is for people with a rare cancer called epithelioid haemangioendothelioma (EHE). Researchers will collect medical information, blood samples, and tumor tissue to look for natural substances (biomarkers) that may help predict how the disease behaves. They will also create lab-grown tumor models to test potential drugs in the future. The goal is to better understand EHE and find new ways to treat it.